Article Information
History
- September 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Amélie Trinquand1,2,
- Adriana Plesa3,
- Chrystelle Abdo1,
- Nathalie Aladjidi4,
- Charlotte Rigaud5,
- Aurore Touzart1,
- Ludovic Lhermitte1,
- Arnaud Petit6,
- Katell Michaux7,
- Charlotte Jung7,
- Catherine Chassagne-Clement8,
- Vahid Asnafi1,
- Yves Bertrand7,
- Nathalie Garnier7 and
- Elizabeth Macintyre1,*
- 1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
- 2National Children’s Research Centre at Children’s Health Ireland, Dublin, Ireland
- 3Laboratoire d’Hématologie, Hospices Civiles de Lyon, Lyon, France
- 4Unité d’Hématologie et Cancérologie pédiatrique/CEREVANCE, CHU Bordeaux, Bordeaux, France
- 5Oncologie Pédiatrique, Institut Gustave Roussy, Villejuif
- 6Service d’Hématologie et d’Oncologie pédiatrique, AP-HP, Hôpital Armand Trousseau, Sorbonne Université, Paris, France
- 7Institut d’Hématologie et d’Oncologie Pédiatrique, Hospices Civiles de Lyon, Lyon
- 8Département de Biopathologie, Centre Leon Berard, Lyon, France
- ↵*Corresponding author: Elizabeth Macintyre, elizabeth.macintyre{at}aphp.fr
Posted September 09, 2020.
Towards molecular stratification of pediatric T-cell lymphoblastic lymphomas based on Minimal Disseminated Disease and NOTCH1/FBXW7 mutational status: the French EURO-LB02 experience
